Literature DB >> 26441270

OUTER RETINA CAPILLARY INVASION AND ELLIPSOID ZONE LOSS IN MACULAR TELANGIECTASIA TYPE 2 IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Alain Gaudric1, Valérie Krivosic, Ramin Tadayoni.   

Abstract

PURPOSE: Macular telangiectasia Type 2 (MacTel2) is a neurodegenerative and vascular disease limited to the macular area, resulting ultimately in Muller cell and photoreceptor loss and intra or subretinal proliferation. Optical coherence tomography angiography was used to correlate the proliferation of capillaries in the outer retina with the topography of the ellipsoid zone (EZ) loss.
METHODS: Thirty eyes of 15 patients with MacTel2 were examined using optical coherence tomography angiography. Images of the superficial and deep capillary plexus were analyzed and compared with en-face angio-flow images of the outer retina and en-face image of the EZ.
RESULTS: Twenty-one eyes were available for the study, including 12 with invasion of the outer retina capillary on optical coherence tomography angiography but without subretinal neovascularization. The outer retina capillary proliferation had a radial pattern in eight cases, formed loops in four, and was circumscribed to an area of EZ loss on en-face images. In nine cases, there was no outer capillary proliferation including two cases with foci of EZ loss.
CONCLUSION: Optical coherence tomography angiography shows capillary proliferation in the outer retina corresponding to areas of EZ loss, which could be a useful marker to monitor the efficacy of possible treatments in MacTel2 disease.

Entities:  

Mesh:

Year:  2015        PMID: 26441270     DOI: 10.1097/IAE.0000000000000799

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  12 in total

1.  One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy.

Authors:  Yu Jeong Park; Suhwan Lee; Young Hee Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-10       Impact factor: 3.535

Review 2.  The fundus photo has met its match: optical coherence tomography and adaptive optics ophthalmoscopy are here to stay.

Authors:  Jessica I W Morgan
Journal:  Ophthalmic Physiol Opt       Date:  2016-05       Impact factor: 3.117

Review 3.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

Review 4.  Optical Coherence Tomography Angiography.

Authors:  Simon S Gao; Yali Jia; Miao Zhang; Johnny P Su; Gangjun Liu; Thomas S Hwang; Steven T Bailey; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

5.  Intraobserver Repeatability and Interobserver Reproducibility of Ellipsoid Zone Measurements in Retinitis Pigmentosa.

Authors:  Margaret R Strampe; Alison L Huckenpahler; Brian P Higgins; Sergey Tarima; Alexis Visotcky; Kimberly E Stepien; Christine N Kay; Joseph Carroll
Journal:  Transl Vis Sci Technol       Date:  2018-06-04       Impact factor: 3.283

6.  Multimodal imaging of macular telangiectasia type 2 in a pediatric patient.

Authors:  Magdy Moussa; Mahmoud Leila; Omar Moussa
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-01

7.  Optical coherence tomography angiography: Technical principles and clinical applications in ophthalmology.

Authors:  Ahmed M Hagag; Simon S Gao; Yali Jia; David Huang
Journal:  Taiwan J Ophthalmol       Date:  2017-09-19

8.  OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.

Authors:  Anne P Runkle; Peter K Kaiser; Sunil K Srivastava; Andrew P Schachat; Jamie L Reese; Justis P Ehlers
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-07-01       Impact factor: 4.799

9.  Perivenular Capillary Loss: An Early, Quantifiable Change in Macular Telangiectasia Type 2.

Authors:  Paul S Micevych; Brian T Soetikno; Amani A Fawzi
Journal:  Transl Vis Sci Technol       Date:  2020-03-09       Impact factor: 3.283

10.  Overlap between telangiectasia and photoreceptor loss increases with progression of macular telangiectasia type 2.

Authors:  Paul S Micevych; Hee Eun Lee; Amani A Fawzi
Journal:  PLoS One       Date:  2019-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.